Yijun Huang, Ph.D.

Current Position

Postdoctoral Researcher

Ph.D., University of Pittsburgh, Pharmaceutical Sciences (2011)

Huang Y, Wolf S, Koes D, Popowicz GM, Camacho CJ, Holak TA, Doemling A,. (2012). Exhaustive Fluorine Scanning toward Potent p53-Mdm2 Antagonists.. ChemMedChem 7: 49-52.

Huang Y, Doemling A,. (2011). The Gewald multicomponent reaction.. Molecular diversity 15: 3-33.

Czarna A, Beck B, Srivastava S, Popowicz GM, Wolf S, Huang Y, Bista M, Holak TA, Doemling A,. (2010). Robust generation of lead compounds for protein-protein interactions by computational and MCR chemistry: p53/Hdm2 antagonists.. Angewandte Chemie (International ed. in English) 49: 5352-6.

Doemling A, Huang Y. (2010). Piperazine Scaffolds via Isocyanide-based Multicomponent Reactions.. Synthesis 2859-2883.

Huang Y, Doemling A,. (2010). 1,4-Thienodiazepine-2,5-diones via MCR (II): scaffold hopping by Gewald and Ugi-deprotection-cyclization strategy.. Chemical biology & drug design 76: 130-41.

Huang Y, Wolf S, Bista M, Meireles L, Camacho C, Holak TA, Doemling A,. (2010). 1,4-Thienodiazepine-2,5-diones via MCR (I): synthesis, virtual space and p53-Mdm2 activity.. Chemical biology & drug design 76: 116-29.